HomeUS StocksABBV

A

AbbVie Inc

ABBV Share PriceHealthcare

$ 250.89

-0.75 (-0.30%)loss
as on 02 Jul 2026 at 01:29 AM

NYSE

analyst81.82% Buy
Overview
News
History
Fundamentals
Investment Returns
Financials
Balance Sheet
Cash Flow
Peers
Bulb

As on 02 Jul 2026 01:29 AM AbbVie Inc opened at $250.75 while its previous close was at $251.64. In the trading session ABBV reached a high of $251.80 and low of $247.56. The total number of shares traded is 37,72,717. Based on analyst ratings the stock has 81.82% Buy, 0% Sell and 18.18% Hold.

TradingViewarrow

ABBV Stock Performance

Markets Today

High

251.80

Low

247.56

Open at

250.75

Prev Close

251.64

Volumes

37,72,717

Price Movement

247.56251.80
1.35%Loss
down side
up side
0.36%Profit

Historical Performance

3 M High

255.99

3 M Low

190.75

1 Yr High

255.99

1 Yr Low

181.75

3 Yr High

255.99

3 Yr Low

132.70

5 Yr High

255.99

5 Yr Low

105.56

1-Year Performance

181.75255.99
38.04%Loss
down side
up side
1.99%Profit

ABBV Analyst Rating

Buy

Analysts have suggested that investors can Buy this Stock

- By ViewTrade from 22 analysts

Buy

81.82%

Hold

18.18%

Sell

0%

ABBV Latest News



ABBV Share Price History

Close Price

Volume

ABBV share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
30 Jun 2026254.95251.26
-1.45% Loss
257.14245.3740,71,839
29 Jun 2026252.94254.26
0.52% profit
255.99245.3770,44,016
26 Jun 2026245.47251.48
2.45% profit
252.20244.791,01,87,516
25 Jun 2026234.59243.34
3.73% profit
244.61234.5964,33,767
24 Jun 2026235.23234.83
-0.17% Loss
237.36232.9544,43,333
23 Jun 2026232.83234.82
0.85% profit
235.31231.5853,04,047
22 Jun 2026222.60229.88
3.27% profit
232.32221.7572,53,966
18 Jun 2026221.61216.69
-2.22% Loss
222.19215.3748,33,947
17 Jun 2026222.51221.08
-0.64% Loss
222.81218.8327,20,996
16 Jun 2026221.83222.39
0.25% profit
224.00219.1535,67,400

ABBV Fundamentals

Company Valuation

Market Cap

$4,43,271M

PE Ratio

102.39

PEG Ratio

-

PB Ratio

-

ROE

-

ROCE

9.63%

ABBVIE INC Return Calculator

You have invested
Investment Period

Current value of $10,000 invested 5 years ago, as on today

$ 0

Gain

$ 10,000 (122.74%)

Note: Past profits do not guarantee future returns.

ABBV Investment Returns

1 Week

1 Month

3 Months

6 Months

ABBV Financials Summary

Revenue
EBITDA
Net Profit
EPS
Revenue

In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
13,34315,42315,77616,6180

ABBV Financials

Income Statement

In USD

Quarterly StatementMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
13,34315,42315,77616,6180
Expenses9,3629,70611,19210,8090
Operating Profit3,9815,7174,5845,8090
Other Income-1,441-2,639-503-1,2100
6,0207,7676,6477,7960
Interest2,3204,1633,8703,1410
Depreciation2,0392,0502,0631,9870
1,6611,5547142,6680
Net Profit1,2869381861,8160
EPS11010

Balance Sheet

In USD

Yearly Balance SheetSep 2024Mar 2025Jun 2025Sep 2025Mar 2026
1,43,4221,36,1651,37,1821,33,8981,36,463
Fixed Assets5,1415,2375,2835,4835,687
Current Assets27,78527,67529,26128,53933,529
1,43,4221,36,1651,37,1821,33,8981,36,463
Share Capital21,17821,82622,00522,30922,980
Reserve & Surplus-7,298-11,269-13,041-15,808-19,025
Non Current Liabilities94,28998,30097,55397,1061,00,975
Current Liabilities43,06236,40339,76739,39142,100

Cash Flow

In USD

Quarterly Cash FlowDec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Cash from Operating7,0481,6355,1537,0245,218
Cash from Investing-1,874-735-1,181-3,264-1,463
Cash from Financing-6,861-1,258-2,710-4,590-4,166
Net Cash Flow-1,687-3581,262-830-411

ABBV Revenue Growth

All values are in USD

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-2561,160
8.57% Profit
4,226
-1.22% Loss
FY 2023-2456,334
3.71% Profit
4,278
-12.03% Loss
FY 2022-2354,318
-6.44% Loss
4,863
-58.91% Loss

ABBV Similar Stocks

Stock NamePrice
Eli Lilly and Co

L

Eli Lilly and Co

$1,199.43-2.48%loss
Johnson & Johnson

J

Johnson & Johnson

$253.97-1.76%loss
Novartis AG

N

Novartis AG

$156.72-0.55%loss
Merck & Co Inc

M

Merck & Co Inc

$128.50-0.68%loss
AstraZeneca PLC

A

AstraZeneca PLC

$189.62-0.70%loss

US Indices Today

Index NamePrice

US Top Gainers Today

Stock NamePrice

US Top Losers Today

Stock NamePrice

What's New In The US Market

Invest in US Stocks with Dhan

Start building a global portfolio from just $1.

4.5 ratings

4.0 ratings

Dhan US Stocks App

Explore  |  Sitemap

*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.


For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors